Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
GE23077 A1/B1
110
CHF
CHF 110.00
In stock
AG-CN2-0305-M0011 mgCHF 110.00
AG-CN2-0305-M0055 mgCHF 380.00
AG-CN2-0305-M02525 mgCHF 1'140.00
Product Details | |
---|---|
Synonyms | Antibiotic GE23077A1/Antibiotic GE23077B1 Mixture |
Product Type | Chemical |
Properties | |
Formula |
C31H51N9O16 [A1] C31H49N9O16 [B1] |
MW |
805.8 [A1] 803.8 [B1] |
CAS |
752989-46-1 [Mixture A1/B1] 752989-45-0 [A1] 752989-44-9 [B1] |
Source/Host Chemicals | Isolated from Actinomadura sp. |
Purity Chemicals | ≥70% (HPLC, for A1/B1) |
Appearance | White to off-white powder. |
Solubility | Soluble in DMSO or water. |
Identity | Determined by 1H-NMR and MS. |
Declaration | Manufactured by Naicons Srl. |
Other Product Data |
Purity Note:The purity is referred exclusively to the main congener(s), the sample also contains minor related congeners. See: Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization: I. Ciciliato, et al.; J. Antibiot. 57, 210 (2004) |
InChi Key | LHEVPJVFNYHCLJ-USIKRYRBSA-N |
Smiles | O=C1NC(CNC(/C(C)=C/C)=O)C(NC(CO)C(NC(C(C)C)C(NC(C(NC(C(C)O)C(NCC(O)C(NC1C(O)=O)=O)=O)=O)C(C(C(N)=O)O)O)=O)=O)=O.O=C2NC(CNC(C(C)CC)=O)C(NC(CO)C(NC(C(C)C)C(NC(C(NC(C(C)O)C(NCC(O)C(NC2C(O)=O)=O)=O)=O)C(C(C(N)=O)O)O)=O)=O)=O |
Shipping and Handling | |
Shipping | AMBIENT |
Short Term Storage | +4°C |
Long Term Storage | -20°C |
Handling Advice |
Keep cool and dry. Protect from light. Protect from light when in solution. |
Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
Documents | |
MSDS | Download PDF |
Product Specification Sheet | |
Datasheet | Download PDF |
Description
- Cyclic heptapeptide antibiotic.
- Potent and selective inhibitor of bacterial RNA polymerase (RNAP). Inhibits Gram-positive (Bacillus subtilis) and Gram-negative (Escherichia coli) RNAPs with IC50 ~20nM, whereas it is not active on E. coli DNA polymerase or on eukaryotic (wheat germ) RNAP II (IC50 values >100µM).
- Even though of its potent activity in vitro on purified bacterial RNAPs, it shows a narrow spectrum of antimicrobial activity in vivo on Gram-positive and Gram-negative bacteria, due to lack of membrane permeability.
- Acts at the level of transcription initiation. Binds directly to the bacterial RNA polymerase (RNAP) active-center 'i' and 'i+1' nucleotide binding sites, preventing the binding of initiating nucleotides and thereby preventing transcription initiation.
- Tool for mechanistic studies on bacterial RNAP and for potential anti-infective drug discovery.
Product References
- Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. I. Taxonomy, isolation and characterization: I. Ciciliato, et al.; J. Antibiot. 57, 210 (2004)
- Mode of action of the microbial metabolite GE23077, a novel potent and selective inhibitor of bacterial RNA polymerase: E. Sarubbi, et al.; Eur. J. Biochem. 271, 3146 (2004)
- Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. II. Structure elucidation: A. Marazzi, et al.; J. Antibiot. 58, 260 (2005)
- Antibiotics GE23077, novel inhibitors of bacterial RNA polymerase. Part 3: Chemical derivatization: R. Mariani, et al.; Bioorg. Med. Chem. Lett. 15, 3748 (2005)
- GE23077 binds to the RNA polymerase 'i' and 'i+1' sites and prevents the binding of initiating nucleotides: Y. Zhang, et al.; Elife 3, e02450 (2014)